Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

BerGenBio - Disclosure of shareholding

Oncoinvent
Investinor Direkte AS ("Investinor"), has on 21 February 2025 sold 39,947 shares
in BerGenBio ASA ("BerGenBio"). Following the transaction, Investinor now holds
1,915,433 shares in BerGenBio, corresponding to 4.90% of the share capital.

This disclosure is made pursuant to sections 4-2 and 4-3 of the Norwegian
Securities Trading Act and is subject to the disclosure requirement pursuant to
section 5-12 of the Norwegian Securities Trading Act.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.